Cargando…
Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy
Palmitoyl ascorbate (PA) as an antioxidant has the potential for the treatment of cancer. In the present study, a nanocarrier system was developed for co-delivery of docetaxel (DOC) with palmitoyl ascorbate and the therapeutic efficacy of a combination drug regimen was investigated. For this purpose...
Autores principales: | Li, Junxiu, Guo, Chaorui, Feng, Fan, Fan, Ali, Dai, Yu, Li, Ning, Zhao, Di, Chen, Xijing, Lu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146911/ https://www.ncbi.nlm.nih.gov/pubmed/27934917 http://dx.doi.org/10.1038/srep38787 |
Ejemplares similares
-
Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency
por: Wang, Tianqi, et al.
Publicado: (2017) -
Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin
por: Ye, Xi, et al.
Publicado: (2022) -
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
por: Lei, Meng, et al.
Publicado: (2019) -
The influence of nanocarrier architectures on antitumor efficacy of docetaxel nanoparticles
por: Dong, Zhengqi, et al.
Publicado: (2020) -
Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer
por: Wang, Shuhang, et al.
Publicado: (2021)